HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Laura Borsi Selected Research

Laura Borsi Research Topics

Disease

18Neoplasms (Cancer)
08/2013 - 03/2002
6Carcinoma (Carcinomatosis)
04/2010 - 07/2004
3Necrosis
08/2013 - 07/2010
3Squamous Cell Carcinoma of Head and Neck
01/2007 - 08/2005
3Adenocarcinoma
01/2005 - 01/2003
2Fibrosarcoma
08/2013 - 04/2006
1Osteosarcoma (Osteogenic Sarcoma)
08/2013
1Arthritis (Polyarthritis)
11/2011
1Neoplasm Metastasis (Metastasis)
09/2011
1Esophageal Neoplasms (Esophageal Cancer)
02/2011
1Neuroblastoma
07/2010
1Renal Cell Carcinoma (Grawitz Tumor)
04/2010
1Cystitis
10/2009
1Fibrosis (Cirrhosis)
07/2008
1Myocarditis (Carditis)
07/2008
1Hematologic Neoplasms (Hematological Malignancy)
06/2008
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2005
1Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
07/2004
1Prostatic Intraepithelial Neoplasia
07/2004
1Colorectal Neoplasms (Colorectal Cancer)
01/2003
1Teratocarcinoma
12/2002
1Astrocytoma (Pilocytic Astrocytoma)
11/2002
1Vascular Tissue Neoplasms
03/2002

Drug/Important Bio-Agent (IBA)

11Fibronectins (Fibronectin)IBA
08/2013 - 03/2002
11Proteins (Proteins, Gene)FDA Link
08/2013 - 03/2002
7TenascinIBA
10/2009 - 01/2003
6Immunoglobulin FragmentsIBA
08/2013 - 12/2002
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2010 - 06/2003
4Protein Isoforms (Isoforms)IBA
02/2011 - 03/2002
3Melphalan (Alkeran)FDA LinkGeneric
08/2013 - 04/2006
3AntibodiesIBA
04/2010 - 11/2002
3Monoclonal AntibodiesIBA
06/2008 - 12/2002
3KalininIBA
01/2007 - 08/2005
3CytokinesIBA
01/2005 - 03/2002
2CollagenIBA
11/2011 - 01/2003
2Extracellular Matrix ProteinsIBA
09/2011 - 01/2003
2ErbB Receptors (EGF Receptor)IBA
02/2011 - 08/2005
2Therapeutic UsesIBA
07/2010 - 06/2003
2Interleukin-2 (IL2)IBA
07/2010 - 03/2002
2Messenger RNA (mRNA)IBA
08/2006 - 07/2004
1GemcitabineFDA Link
08/2013
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
09/2011
1PeriostinIBA
09/2011
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2011
1vandetanib (ZD6474)IBA
02/2011
1Angiogenesis InhibitorsIBA
02/2011
1Immunoconjugates (Immunoconjugate)IBA
02/2011
1Tyrosine Kinase InhibitorsIBA
02/2011
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
02/2011
1RNA Precursors (Precursor, mRNA)IBA
02/2010
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
07/2008
1Hydroxyproline (4 Hydroxyproline)IBA
07/2008
1platelet-derived growth factor AIBA
07/2008
1Phosphotransferases (Kinase)IBA
07/2008
1Platelet-Derived Growth FactorIBA
07/2008
1Imatinib Mesylate (Gleevec)FDA Link
07/2008
1AntigensIBA
06/2008
1F8 monoclonal antibodyIBA
06/2008
1Amino AcidsFDA Link
06/2008
1p38 Mitogen-Activated Protein KinasesIBA
08/2005
1Interleukin-6 (Interleukin 6)IBA
01/2005
1Collagen Type V (Type V Collagen)IBA
01/2005
1RNA (Ribonucleic Acid)IBA
07/2004
1Phenobarbital (Luminal)FDA Link
07/2004
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
07/2004
1Interleukin-12 (IL 12)IBA
06/2003
1LigandsIBA
12/2002
1Calmodulin (Calcium-Dependent Activator Protein)IBA
12/2002
1Immunoglobulin G (IgG)IBA
11/2002
1Factor VIII (Coagulation Factor VIII)IBA
11/2002
1Staphylococcal Protein A (Protein A)IBA
03/2002
1Interferon-gamma (Interferon, gamma)IBA
03/2002

Therapy/Procedure

8Therapeutics
08/2013 - 12/2002
2Lasers (Laser)
01/2007 - 07/2006
1Intravenous Injections
06/2008
1Aftercare (After-Treatment)
12/2007